{"id":"W4210372584","doi":"10.51731/cjht.2022.252","title":"Pembrolizumab (Keytruda)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Reimbursement; Medicine; Esophagus; Adenocarcinoma; Chemotherapy; Drug; Oncology; Internal medicine; General surgery; Intensive care medicine; Cancer; Pharmacology; Immunotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004222271,0.0002634934,0.0002317677,0.0005817783,0.0002260448,0.0007223829,0.0003167584,0.0004980635,0.01511856],"category_scores_gemma":[0.0008585378,0.00008661553,0.0003629809,0.0004032864,0.0002158854,0.0005879881,0.0003208129,0.0006876073,0.003152861],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001197778,"about_ca_system_score_gemma":0.001278504,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009167955,"about_ca_topic_score_gemma":0.02461579,"domain_scores_codex":[0.9997666,0.00005035015,0.00002724814,0.00004126283,0.00008010345,0.00003439838],"domain_scores_gemma":[0.9997786,0.00004844341,0.00006552537,0.000009667528,0.0000686757,0.00002907147],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004947658,0.00004760524,0.0004156785,0.003548843,0.0001006623,0.0001402102,0.00002756215,0.00009784967,0.003349828,0.002754066,0.06366125,0.9253617],"study_design_scores_gemma":[0.0002877332,0.0004942542,0.003392499,0.002262368,0.0001784905,0.0009200856,0.00003565145,0.00008731339,0.003793307,0.0005082106,0.9880271,0.00001288467],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.008700907,0.8728309,0.001436537,0.007283395,0.001636279,0.0002411241,0.001341329,0.0002421036,0.1062874],"genre_scores_gemma":[0.1519988,0.7161943,0.005512872,0.01176623,0.0009220225,0.0002731832,0.002370985,0.00004173915,0.1109198],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.01511856,"threshold_uncertainty_score":0.05057663,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03679924395480353,"score_gpt":0.3275468292165374,"score_spread":0.2907475852617338,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}